TORONTO – TORONTO (AP) _ Trillium Therapeutics Inc. (TRIL) on Wednesday reported a loss of $2.2 million in its fourth quarter.
The Toronto-based company said it had a loss of 28 cents per share.
For the year, the company reported profit of $11 million, or $1.66 per share.
Trillium shares have decreased 39 per cent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $7.74, a drop of 50 per cent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TRIL at http://www.zacks.com/ap/TRIL
Keywords: Trillium Therapeutics, Earnings Report